Terms: = Germ cell tumor AND DDX5, HLR1, 1655, ENSG00000108654, P17844, DKFZp686J01190, p68, G17P1, HUMP68
31 results:
1. Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain.
Lamas C; Cámara R; Fajardo C; Remon-Ruiz P; Biagetti B; Guerrero-Pérez F; Araujo-Castro M; Mora M; Hanzu F; Iglesias P; García-Centeno R; Soto A
Front Endocrinol (Lausanne); 2023; 14():1204206. PubMed ID: 37720528
[TBL] [Abstract] [Full Text] [Related]
2. Hemorrhagic presentation of previously silent brain tumors.
Turkkan A; Khezri MK; Eser P; Kuytu T; Tolunay S; Bekar A
Neurocirugia (Astur : Engl Ed); 2023; 34(4):177-185. PubMed ID: 36775742
[TBL] [Abstract] [Full Text] [Related]
3. Ovarian teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis: a clinical analysis of 5 cases.
He LD; Zhang X; Wu J
Ginekol Pol; 2023; 94(6):451-455. PubMed ID: 36597802
[TBL] [Abstract] [Full Text] [Related]
4. IDH-mutant gliomas with additional class-defining molecular events.
Ahrendsen JT; Torre M; Meredith DM; Hornick JL; Reardon DA; Wen PY; Yeo KK; Malinowski S; Ligon KL; Ramkissoon S; Alexandrescu S
Mod Pathol; 2021 Jul; 34(7):1236-1244. PubMed ID: 33772213
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA PRADX-mediated recruitment of PRC2/ddx5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis.
Li Y; Liu X; Cui X; Tan Y; Wang Q; Wang Y; Xu C; Fang C; Kang C
Theranostics; 2021; 11(9):4516-4530. PubMed ID: 33754075
[No Abstract] [Full Text] [Related]
6. Noninvasive Determination of
Bhandari AP; Liong R; Koppen J; Murthy SV; Lasocki A
AJNR Am J Neuroradiol; 2021 Jan; 42(1):94-101. PubMed ID: 33243896
[TBL] [Abstract] [Full Text] [Related]
7. LINC01116 promotes tumor proliferation and neutrophil recruitment via ddx5-mediated regulation of IL-1β in glioma cell.
Wang T; Cao L; Dong X; Wu F; De W; Huang L; Wan Q
Cell Death Dis; 2020 May; 11(5):302. PubMed ID: 32358484
[TBL] [Abstract] [Full Text] [Related]
8. Upregulation of DEAD box helicase 5 and 17 are correlated with the progression and poor prognosis in gliomas.
Luo Q; Que T; Luo H; Meng Y; Chen X; Huang H; Hu R; Luo K; Zheng C; Yan P; Gong J; Fu H; Liu J; Tang Q; Huang G
Pathol Res Pract; 2020 Mar; 216(3):152828. PubMed ID: 32008867
[TBL] [Abstract] [Full Text] [Related]
9. Long Noncoding RNA NHEG1 Drives β-Catenin Transactivation and Neuroblastoma Progression through Interacting with ddx5.
Zhao X; Li D; Yang F; Lian H; Wang J; Wang X; Fang E; Song H; Hu A; Guo Y; Liu Y; Li H; Chen Y; Huang K; Zheng L; Tong Q
Mol Ther; 2020 Mar; 28(3):946-962. PubMed ID: 31982037
[TBL] [Abstract] [Full Text] [Related]
10. Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults.
Ferrante di Ruffano L; Dinnes J; Chuchu N; Bayliss SE; Takwoingi Y; Davenport C; Matin RN; O'Sullivan C; Roskell D; Deeks JJ; Williams HC;
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013187. PubMed ID: 30521689
[TBL] [Abstract] [Full Text] [Related]
11. p68 RNA helicase promotes invasion of glioma cells through negatively regulating DUSP5.
Wang R; Bao HB; Du WZ; Chen XF; Liu HL; Han DY; Wang LG; Wu JN; Wang CL; Yang MC; Liu ZW; Zhang N; Teng L
Cancer Sci; 2019 Jan; 110(1):107-117. PubMed ID: 30387548
[TBL] [Abstract] [Full Text] [Related]
12. Identification of Key Candidate Proteins and Pathways Associated with Temozolomide Resistance in Glioblastoma Based on Subcellular Proteomics and Bioinformatical Analysis.
Yi GZ; Xiang W; Feng WY; Chen ZY; Li YM; Deng SZ; Guo ML; Zhao L; Sun XG; He MY; Qi ST; Liu YW
Biomed Res Int; 2018; 2018():5238760. PubMed ID: 29687002
[TBL] [Abstract] [Full Text] [Related]
13. A comparison between oral chemotherapy combined with radiotherapy and radiotherapy for newly diagnosed glioblastoma: A systematic review and meta-analysis.
Wang Z; Yang G; Zhang YY; Yao Y; Dong LH
Medicine (Baltimore); 2017 Nov; 96(44):e8444. PubMed ID: 29095287
[TBL] [Abstract] [Full Text] [Related]
14. End-of-life caregivers' perception of medical and psychological support during the final weeks of glioma patients: a questionnaire-based survey.
Heese O; Vogeler E; Martens T; Schnell O; Tonn JC; Simon M; Schramm J; Krex D; Schackert G; Reithmeier T; Nikkhah G; Sabel M; Steiger HJ; Schlegel U; Löffler M; Weller M; Westphal M;
Neuro Oncol; 2013 Sep; 15(9):1251-6. PubMed ID: 23814266
[TBL] [Abstract] [Full Text] [Related]
15. Common genetic variants in the microRNA biogenesis pathway are associated with malignant peripheral nerve sheath tumor risk in a Chinese population.
Weng Y; Chen Y; Chen J; Liu Y; Bao T
Cancer Epidemiol; 2013 Dec; 37(6):913-6. PubMed ID: 23763827
[TBL] [Abstract] [Full Text] [Related]
16. [Partial hydatidiform mole in Morocco: an epidemiological and clinical study].
Boufettal H; Coullin P; Mahdaoui S; Noun M; Hermas S; Samouh N
East Mediterr Health J; 2012 Jul; 18(7):755-61. PubMed ID: 22891525
[TBL] [Abstract] [Full Text] [Related]
17. p68 RNA helicase promotes glioma cell proliferation in vitro and in vivo via direct regulation of NF-κB transcription factor p50.
Wang R; Jiao Z; Li R; Yue H; Chen L
Neuro Oncol; 2012 Sep; 14(9):1116-24. PubMed ID: 22810421
[TBL] [Abstract] [Full Text] [Related]
18. A double tyrosine phosphorylation of p68 RNA helicase confers resistance to TRAIL-induced apoptosis.
Yang L; Lin C; Sun SY; Zhao S; Liu ZR
Oncogene; 2007 Sep; 26(41):6082-92. PubMed ID: 17384675
[TBL] [Abstract] [Full Text] [Related]
19. Evolution of treatment of high-risk metastatic gestational trophoblastic tumors: Ain Shams University experience.
El-Lamie IK; El Sayed HM; Badawie AG; Bayomi WA; El-Ghazaly HA; Khalaf-Allah AE; El-Mahallawy MN; El-Lamie KI
Int J Gynecol Cancer; 2006; 16(2):866-74. PubMed ID: 16681775
[TBL] [Abstract] [Full Text] [Related]
20. Classification of malignant gliomas by infrared spectroscopy and linear discriminant analysis.
Krafft C; Thümmler K; Sobottka SB; Schackert G; Salzer R
Biopolymers; 2006 Jul; 82(4):301-5. PubMed ID: 16506167
[TBL] [Abstract] [Full Text] [Related]
[Next]
